Popular Weight Loss Drugs Linked to Lower Risk of Breast Cancer - ScienceAlert
New observational studies presented at the ASCO meeting suggest that GLP-1 weight loss drugs like Ozempic may be linked to a lower risk of breast cancer. Researchers found that users had significantly lower odds of diagnosis and better outcomes if diagnosed.
Why it matters
Suggests potential secondary health benefits for widely used weight loss medications, which could influence future medical guidelines and public health.
Add ScienceAlert on Google (Curly_photo/Moment/Getty Images) The potential benefits of GLP-1 drugs, like Ozempic or Wegovy, are stacking up.
Reports on scientific findings with appropriate caveats about the observational nature of the studies.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in